Johnson & Johnson
An insider at 3 companies in coverage, as reported on Form 4. SEC CIK 200406. Latest Form 4 filed Aug 25, 2023.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Kenvue Inc.KVUE | 10% owner | 1 | 2023-08-23 | 2023-08-23 |
| Minerva Neurosciences, Inc.NERV | 10% owner | 3 | 2015-03-13 | 2017-08-29 |
| Protagonist Therapeutics, IncPTGX | 10% owner | 5 | 2016-08-16 | 2016-08-16 |
Transactions: 9
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2023-08-23 | Kenvue Inc.10% owner | Other | 1,533,830,450 | not reported | not reported | Form 4 |
| 2017-08-29 | Minerva Neurosciences, Inc.10% owner | Other | 3,892,256 | $0.0001 | $389.23 | Form 4 |
| 2016-08-16 | Protagonist Therapeutics, Inc10% owner | ConversionSeries C Preferred Stock | 13,054,830 | $0.00 | $0 | Form 4 |
| 2016-08-16 | Protagonist Therapeutics, Inc10% owner | ConversionSeries B Preferred Stock | 14,000,000 | $0.00 | $0 | Form 4 |
| 2016-08-16 | Protagonist Therapeutics, Inc10% owner | Purchase | 583,333 | $12.00 | $7.0m | Form 4 |
| 2016-08-16 | Protagonist Therapeutics, Inc10% owner | Conversion | 900,333 | not reported | not reported | Form 4 |
| 2016-08-16 | Protagonist Therapeutics, Inc10% owner | Conversion | 965,517 | not reported | not reported | Form 4 |
| 2015-03-13 | Minerva Neurosciences, Inc.10% owner | PurchaseWarrants (right to buy) | 607,903 | $0.125 | $76.0k | Form 4 |
| 2015-03-13 | Minerva Neurosciences, Inc.10% owner | Purchase | 607,903 | $4.81 | $2.9m | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 10:32 ET. Listed shows no prices and gives no investment advice.